Globus Medical Stock Analysis

GMED Stock  USD 51.82  0.15  0.29%   
Globus Medical is undervalued with Real Value of 60.04 and Target Price of 67.25. The main objective of Globus Medical stock analysis is to determine its intrinsic value, which is an estimate of what Globus Medical is worth, separate from its market price. There are two main types of Globus Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Globus Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Globus Medical's stock to identify patterns and trends that may indicate its future price movements.
The Globus Medical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Globus Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Globus Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Globus Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Globus Stock Analysis Notes

About 97.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.75. Some equities with similar Price to Book (P/B) outperform the market in the long run. Globus Medical has Price/Earnings To Growth (PEG) ratio of 1.75. The entity had not issued any dividends in recent years. Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people. To learn more about Globus Medical call David Paul at 610 930 1800 or check out https://www.globusmedical.com.

Globus Medical Quarterly Total Revenue

616.53 Million

Globus Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Globus Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Globus Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Globus Medical generated a negative expected return over the last 90 days
Over 97.0% of the company shares are owned by institutional investors
Latest headline from businesswire.com: Upstream Security erhlt Investitionen von Cisco bei rasant steigender Nachfrage nach IoT-Cybersicherheit

Globus Medical Upcoming and Recent Events

Earnings reports are used by Globus Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Globus Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Globus Largest EPS Surprises

Earnings surprises can significantly impact Globus Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-11-03
2015-09-300.250.280.0312 
2014-10-30
2014-09-300.210.240.0314 
2014-02-26
2013-12-310.220.250.0313 
View All Earnings Estimates

Globus Medical Thematic Classifications

In addition to having Globus Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Obamacare Repeal Idea
Obamacare Repeal
Large healthcare related equities associated with Obamacare
Baby Boomer Prospects Idea
Baby Boomer Prospects
Mega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force
Obamacare Idea
Obamacare
Companies that count on Obamacare to take off

Globus Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Globus Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Globus Medical backward and forwards among themselves. Globus Medical's institutional investor refers to the entity that pools money to purchase Globus Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Champlain Investment Partners, Llc2023-12-31
M
Geode Capital Management, Llc2023-12-31
1.9 M
Dimensional Fund Advisors, Inc.2023-12-31
1.8 M
Norges Bank2023-12-31
1.8 M
Gw&k Investment Management, Llc2023-12-31
1.8 M
Burgundy Asset Management Ltd2023-12-31
1.7 M
Marshall Wace Asset Management Ltd2023-12-31
1.6 M
Van Berkom And Associates Inc2023-12-31
1.6 M
Geneva Capital Management2023-12-31
1.4 M
Vanguard Group Inc2023-12-31
11.3 M
Blackrock Inc2023-12-31
10.8 M
Note, although Globus Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Globus Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Globus Medical's market, we take the total number of its shares issued and multiply it by Globus Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Globus Profitablity

Globus Medical's profitability indicators refer to fundamental financial ratios that showcase Globus Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Globus Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Globus Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Globus Medical's profitability requires more research than a typical breakdown of Globus Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.05  0.04 
Return On Capital Employed 0.03  0.03 
Return On Assets 0.02  0.02 
Return On Equity 0.03  0.03 

Management Efficiency

Globus Medical has return on total asset (ROA) of 0.0477 % which means that it generated a profit of $0.0477 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0421 %, meaning that it created $0.0421 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of April 15, 2024, Return On Tangible Assets is expected to decline to 0.04. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Globus Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 82.5 M, whereas Return On Tangible Assets are forecasted to decline to 0.04.
Last ReportedProjected for Next Year
Book Value Per Share 35.35  37.12 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 14.49  15.22 
Enterprise Value Over EBITDA 15.16  13.00 
Price Book Value Ratio 1.51  1.43 
Enterprise Value Multiple 15.16  13.00 
Price Fair Value 1.51  1.43 
Enterprise Value 0.00  0.00 
The analysis of Globus Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Globus Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Globus Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.104

Technical Drivers

As of the 15th of April 2024, Globus Medical retains the Market Risk Adjusted Performance of (0.04), risk adjusted performance of (0.01), and Standard Deviation of 1.58. Globus Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Globus Medical, which can be compared to its competitors. Please check out Globus Medical information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Globus Medical is priced fairly, providing market reflects its last-minute price of 51.82 per share. Given that Globus Medical has information ratio of (0.08), we strongly advise you to confirm Globus Medical's regular market performance to make sure the company can sustain itself at a future point.

Globus Medical Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Globus Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Globus Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Globus Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Globus Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Globus Medical Predictive Daily Indicators

Globus Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Globus Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Globus Medical Corporate Filings

F4
19th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
5th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
21st of February 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
8K
20th of February 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
13th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
5th of February 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
30th of January 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Globus Medical Forecast Models

Globus Medical's time-series forecasting models are one of many Globus Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Globus Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Globus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Globus Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Globus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Globus Medical. By using and applying Globus Stock analysis, traders can create a robust methodology for identifying Globus entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.11  0.10 
Operating Profit Margin 0.08  0.08 
Net Profit Margin 0.08  0.07 
Gross Profit Margin 0.65  0.85 

Current Globus Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Globus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Globus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
67.25Buy16Odds
Globus Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Globus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Globus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Globus Medical, talking to its executives and customers, or listening to Globus conference calls.
Globus Analyst Advice Details

Globus Stock Analysis Indicators

Globus Medical stock analysis indicators help investors evaluate how Globus Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Globus Medical shares will generate the highest return on investment. By understating and applying Globus Medical stock analysis, traders can identify Globus Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow150.5 M
Long Term Debt417.4 M
Common Stock Shares Outstanding114.6 M
Total Stockholder EquityB
Tax Provision42.5 M
Quarterly Earnings Growth Y O Y-0.788
Property Plant And Equipment Net646.9 M
Cash And Short Term Investments517.8 M
Cash467.3 M
Accounts Payable56.7 M
Net Debt53.1 M
50 Day M A53.2564
Total Current Liabilities392.3 M
Other Operating Expenses1.4 B
Non Current Assets Total3.2 B
Forward Price Earnings19.2308
Non Currrent Assets Other78.6 M
Stock Based Compensation52.7 M
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bonds Directory
Find actively traded corporate debentures issued by US companies
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
1.07
Revenue Per Share
13.87
Quarterly Revenue Growth
1.246
Return On Assets
0.0477
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.